ASX:MVF

Monash IVF Group (MVF) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
9.00 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.46%
Price Target
N/A
MVF stock logo

About Monash IVF Group Stock (ASX:MVF)

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.

MVF Stock News Headlines

Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Monash IVF Group Ltd.
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Monash IVF Group Limited
See More Headlines
Receive MVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Monash IVF Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/27/2018
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
867
Year Founded
N/A

Profitability

Net Income
$23.97 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$235.97 million
Book Value
A$0.71 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.46
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Michael D. Knaap
    CEO, MD & Executive Director
  • Mr. Malik Jainudeen
    Group CFO & Company Secretary
  • Dr. Hamish Hamilton
    Chief Operating Officer
  • Dr. Richard Charles Henshaw M.D.
    Executive Director
  • Dr. Deirdre Zander-Fox BSc. (Hons.)
    Dip. of Mgt, Ph.D., Chief Scientific Officer
  • Mr. Thierry Panthier
    Chief Information Officer
  • Ms. Fiona Allen
    Chief Marketing Officer
  • Ms. Peggy North
    Chief People & Culture Officer
  • Ms. Tedd Fuell
    Chief Governance & Risk Officer
  • Mr. Johannes Lagerwij
    Managing Director of Asia

MVF Stock Analysis - Frequently Asked Questions

How were Monash IVF Group's earnings last quarter?

Monash IVF Group Limited (ASX:MVF) issued its earnings results on Monday, August, 27th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.10 by $0.01. Monash IVF Group had a net margin of 10.16% and a trailing twelve-month return on equity of 8.68%.

Is Monash IVF Group a good dividend stock?

Monash IVF Group (ASX:MVF) pays an annual dividend of A$0.05 per share and currently has a dividend yield of 3.46%. The dividend payout ratio is 83.33%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for MVF.

What other stocks do shareholders of Monash IVF Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Monash IVF Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Surgery Partners (SGRY), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS) and

This page (ASX:MVF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners